Cancer incidence and mortality in Serbia 1999-2009

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Mihajlović, Jovan ^a   Pechlivanoglou, Petros ^a   Miladinov Mikov, Marica ^b,c   Živković, Snežana ^d   Postma, Maarten J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

^d Institute of Public Health of Serbia Dr Milan Jovanovic Batut   (Serbia)

Author keywords

Cancer; Comparison; Incidence; Mortality; Serbia

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; COLORECTAL CANCER; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SERBIA; SEX DIFFERENCE; TREND STUDY; UTERINE CERVIX CANCER;

AGE DISTRIBUTION; AGE FACTORS; CAUSE OF DEATH; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; LINEAR MODELS; MALE; NEOPLASMS; REGISTRIES; SERBIA; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS;

EID: 84872164140     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-18     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Parkin DM, Laara E, Muir CS. Estimates of worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988, 41:184-197. 10.1002/ijc.2910410205, 3338870.
3. Parkin DM, Pisani P, Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993, 54:594-606. 10.1002/ijc.2910540413, 8514451.
4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999, 80:827-841.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 2010, Lyon: International Agency for Research on Cancer., http://globocan.iarc.fr
6. Miljuš D, Vukičević A, Živković S. Cancer incidence and mortality in central Serbia (1999-2007) 2010, Belgrade: Cancer Registry of Serbia, Institute of Public Health of Serbia " Dr Milan Jovanović-Batut" .
7. Stankov S, Stankov K. Descriptive epidemiology of breast cancer in Vojvodina. Breast 2011, 20(2):192-195. 10.1016/j.breast.2010.12.001, 21185723.
8. Petrović V, Miladinov-Mikov M, Dugandžija T. Topographical analyses of lung cancer incidence and mortality in Vojvodina. Arch Oncol 2010, 18(3):71.
9. Vlajinac H, Šipetić-Grujičithomampersa S, Janković S, Marinković J, Kocev N, Marković-Denić L, Bjegović V. Burden of cancer in Serbia. Croat Med J 2006, 47:134-141. 2080367, 16489706.
10. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness. Eur J Cancer 2009, 45:747-755. 10.1016/j.ejca.2008.11.032, 19117750.
11. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part II: completeness. Eur J Cancer 2009, 45:756-764. 10.1016/j.ejca.2008.11.033, 19128954.
12. World Health Organization International classification of diseases and related health problems, 10th revision Volume 1, World Health Organization., http://www.who.int/classifications/icd/en/
13. Statistical Office of the Republic of Serbia Statistical Office of the Republic of Serbia., http://webrzs.stat.gov.rs/Website
14. Segi M. Cancer mortality for selected sites in 24 countries (1950-57) 1960, Sendai: Tohoku University School of Public Health.
15. Dyba T, Hakulinen T. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 2000, 19(13):1741-1752. 10.1002/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O, 10861775.
16. R Development Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing 2009, Austria: Vienna, R Development Core Team., http://www.R-project.org
17. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
18. Sasco AJ, Secretana MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2004, 45(Suppl. 2):S3-S9.
19. IARC Working Group IARC Monographs: On the evaluation of coarcinogenic risks to humans 2010, Lyon: Alcohol consumption, Volume 96, IARC Working Group.
20. O'Rourke M, Djukic J. Welcome to Serbia: feel free to smoke. Tob Control 2008, 17:428-430. 10.1136/tc.2008.027425, 18827037.
21. Knežević T, Miljuš D, Živković S, Plavšić V, Janković J, Savković S. Attributable causes of cancer in Serbia in the year 2005 2008, Belgrade: Institute of Public Health of Serbia " Dr Milan Jovanović-Batut.
22. IARC working group IARC handbooks of cancer prevention 2002, Lyon: Weight control and physical activity, Volume 6, IARC working group.
23. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578. 10.1016/S0140-6736(08)60269-X, 18280327.
24. Pavlović M, Grujić V, Oshaug A. Nutrition and Physical Activity of the Population in Serbia. Nutrition and fitness: obesity, the metabolic syndrome, cardiovascular disease, and cancer 2005, 51-59. Basel: Karger: World Rev Nutr Diet, Simopoulos AP, Volume 94.
25. Döbrossy L. Cancer mortality in central-eastern Europe:facts behind the figures. Lancet Oncol 2002, 3(6):374-381. 8, 10.1016/S1470-2045(02)00778-7, 12107025.
26. Vostakolaei FA, Karim-Kos HE, Janssen-Heijnen MLG, Visser O, Verbeek ALM, Kiemeney LALM. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health 2011, 21(5):573-577. 10.1093/eurpub/ckq120, 20813895.
27. Schrijvers CTM, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP. Deprivation, stage at diagnosis and cancer survival. Int J Cancer 1995, 63(3):324-329. 10.1002/ijc.2910630303, 7591225.
28. Stanimirović B. National program of early detection and treatment of uterine cervical cancer. Arch Oncol 2000, 8(2):61-64.
29. Kesić V, Poljak M, Rogovskaya S. Cervical cancer burden and prevention activities in europe. Cancer Epidemiol Biomark Prev 2012, 21:1423-1433.
30. Peto J, Gilham C, Fletcher O, Ematthews F. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004, 364(9430):249-256. 10.1016/S0140-6736(04)16674-9, 15262102.
31. Blanchard K, Colbert JA, Puri D. Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival. Cancer 2004, 101(3):495-507. 10.1002/cncr.20392, 15274062.
32. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348(9040):1467-1471. 10.1016/S0140-6736(96)03430-7, 8942774.
33. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003, 39(12):1718-1729. 10.1016/S0959-8049(03)00118-7, 12888367.
34. Ciraj-Bjelac O, Štimac FD, Arand{stroke}ić KD, Brkić H. Good reasons to implement quality assurance in nationwide breast cancer screening programs in Croatia and Serbia: Results from a pilot study. Eur J Radiology 2011, 78:122-128.
35. Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, La Vecchia C. The decline in breast cancer mortality in Europe: An update (to 2009). Breast 2012, 21:77-82. 10.1016/j.breast.2011.08.001, 21906943.
36. Janković J, Sipetić S. The rising incidence and mortality of prostate cancer in Belgrade population. Coll Antropol 2011, 35(2):499-503.
37. Arbyn M, et al. The burden of cervical cancer in south-east europe at the beginning of the 21st century. Coll Antropol 2007, 31(Suppl 2):7-10.